Drug developer CombinatoRx Inc. said Monday it will pay its new CEO an annual salary of $450,000 and dole out $325,000 in cash bonuses to several senior executives following the U.S. Food and Drug Administration’s approval of its pain drug Exalgo.
best rates for family health insurance